>>> Only US to US shipping <<<
Clonazepam is a benzodiazepine drug having anxiolytic, anticonvulsant,
muscle relaxant, sedative, and hypnotic properties. It is marketed under
the trade name Rivotril in Argentina, Australia, Brazil, Bulgaria,
Canada, Costa Rica, Ireland, Spain, Italy, and Mexico, and Linotril in
India, South Korea, and other parts of Europe, and under the trade name
Klonopin by Roche in the United States.
Other names such as Ravotril, Rivatril, Iktorivil, Clonex, Paxam, Petril
or Kriadex are known throughout the world. Clonazepam
has an unusually long elimination half-life of 18â€“50 hours, making it
generally considered to be among the long-acting benzodiazepines.
Clonazepam is a chlorinated derivative of nitrazepam and therefore a
Clonazepam has an intermediate onset of action, with a peak blood levels
occurring one to four hours after oral administration. Long-term
effects of benzodiazepines include tolerance, benzodiazepine dependence,
and benzodiazepine withdrawal syndrome, which occurs in a third of
people treated with clonazepam for longer than four weeks. Clonazepam is
classified as a benzodiazepine.
Benzodiazepines such as clonazepam have a fast onset of action and high
effectiveness rate and low toxicity in overdose but, as most
medications, it may have drawbacks due to adverse reactions including
paradoxical effects and drowsiness. The benzodiazepine clorazepate may
be an alternative to clonazepam due to a slow onset of tolerance and
availability in slow-release formulation to counter fluctuations in
blood levels. The pharmacological property of clonazepam as with other
benzodiazepines is the enhancement of the neurotransmitter GABA via
modulation of the GABAA receptor.